Literature DB >> 17112423

Osteoporosis and depression: a historical perspective.

Deborah T Gold1, Samantha Solimeo.   

Abstract

In the early 1980s, researchers studying osteoporosis noted that depression was one of the major negative consequences of bone loss and fractures. These researchers believed that osteoporosis and fractures occurred first, causing a reactive depression. Meanwhile, a similar but distinct psychiatry literature noted that osteoporosis or bone loss appeared to be an undesirable consequence of major depression. Here, depression was seen as the causal factor, and osteoporosis was the outcome. The psychiatric perspective is more biological, based on the presence of hypercorticoidism in depressed individuals. Those who believe that osteoporosis leads to depression point out that depression is a consequence of many chronic illnesses. Regardless of the correct causal order, the strong positive relationship between osteoporosis and depression merits further clinical and research attention in the future.

Entities:  

Mesh:

Year:  2006        PMID: 17112423     DOI: 10.1007/s11914-996-0021-6

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  35 in total

Review 1.  How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.

Authors:  Deborah T Gold; Ivy M Alexander; Mark P Ettinger
Journal:  Ann Pharmacother       Date:  2006-05-30       Impact factor: 3.154

Review 2.  Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes.

Authors:  D F Horrobin; C N Bennett
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1999-04       Impact factor: 4.006

Review 3.  The clinical impact of vertebral fractures: quality of life in women with osteoporosis.

Authors:  D T Gold
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

4.  Bone mineral density and depression: a community study in women.

Authors:  R Coelho; C Silva; A Maia; J Prata; H Barros
Journal:  J Psychosom Res       Date:  1999-01       Impact factor: 3.006

Review 5.  Depression: a major, unrecognized risk factor for osteoporosis?

Authors:  G Cizza; P Ravn; G P Chrousos; P W Gold
Journal:  Trends Endocrinol Metab       Date:  2001-07       Impact factor: 12.015

6.  Balance, mobility, and falls among community-dwelling elderly persons: effects of a rehabilitation exercise program.

Authors:  Kevin M Means; Daniel E Rodell; Patricia S O'Sullivan
Journal:  Am J Phys Med Rehabil       Date:  2005-04       Impact factor: 2.159

7.  Improving psychologic adjustment to chronic illness in cardiac patients. The role of depression and anxiety.

Authors:  Thomas J McLaughlin; Onesky Aupont; Kara Z Bambauer; Peter Stone; Mariquita G Mullan; Jane Colagiovanni; Elaine Polishuk; Michael Johnstone; Steven E Locke
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

8.  Bone mineral density in women with depression.

Authors:  D Michelson; C Stratakis; L Hill; J Reynolds; E Galliven; G Chrousos; P Gold
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

9.  Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong).

Authors:  Samuel Y S Wong; Edith M C Lau; Henry Lynn; P C Leung; Jean Woo; Steve R Cummings; Eric Orwoll
Journal:  Osteoporos Int       Date:  2004-09-23       Impact factor: 4.507

Review 10.  Impact of osteoporosis on quality of life.

Authors:  A Sutcliffe
Journal:  Community Nurse       Date:  1998-08
View more
  19 in total

1.  Serum vitamin D level and bone mineral density in premenopausal Egyptian women with fibromyalgia.

Authors:  Shereem Mohamed Olama; Mohammed K Senna; Mohammed Mohamed Elarman; Galal Elhawary
Journal:  Rheumatol Int       Date:  2012-02-04       Impact factor: 2.631

Review 2.  Adrenal steroids and the metabolic syndrome.

Authors:  Stephen P Thomson; Craig S Stump; L Romayne Kurukulasuriya; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 3.  Impact of the Autonomic Nervous System on the Skeleton.

Authors:  Florent Elefteriou
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 4.  Depression, fracture risk, and bone loss: a meta-analysis of cohort studies.

Authors:  Q Wu; J Liu; J F Gallegos-Orozco; J G Hentz
Journal:  Osteoporos Int       Date:  2010-03-04       Impact factor: 4.507

Review 5.  Depression, selective serotonin reuptake inhibitors, and osteoporosis.

Authors:  Itai Bab; Raz Yirmiya
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

6.  Effects of long-term combination treatment with valproate and atypical antipsychotics on bone mineral density and bone metabolism in premenopausal patients with bipolar disorder: a preliminary study.

Authors:  Jaewon Yang; Sook-Haeng Joe; Moon-Soo Lee; Young-Hoon Ko; In-Kwa Jung; Seung-Hyun Kim
Journal:  Psychiatry Investig       Date:  2011-08-05       Impact factor: 2.505

7.  Expression of prolactin receptors in the duodenum, kidneys and skeletal system during physiological and sulpiride-induced hyperprolactinaemia.

Authors:  Danijela Radojkovic; Milica Pesic; Milan Radojkovic; Dragan Dimic; Marija Vukelic Nikolic; Tatjana Jevtovic Stoimenov; Sasa Radenkovic; Milena Velojic Golubovic; Tatjana Radjenovic Petkovic; Slobodan Antic
Journal:  Endocrine       Date:  2018-08-24       Impact factor: 3.633

8.  Psychological state, quality of life, and body composition in postmenopausal women with osteoporosis in Lithuania.

Authors:  Lina Lasaite; Aurelija Krasauskiene
Journal:  Arch Osteoporos       Date:  2009-12-01       Impact factor: 2.617

Review 9.  Depression and low bone mineral density: a meta-analysis of epidemiologic studies.

Authors:  Q Wu; J H Magnus; J Liu; A F Bencaz; J G Hentz
Journal:  Osteoporos Int       Date:  2009-04-03       Impact factor: 4.507

10.  Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Authors:  Robert H Howland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.